Life Course Perspective on the decision-making process to undergo genetic testing in hereditary cancer at risk families

Aceti, M and Caiata Zufferey, Maria and Pedrazzani, Carla Ambrogina and Schweighoffer, Reka and Baroutsou, V and Burki, N and Chappuis, P and Graffeo-Galbiati, R and Monnerat, C and Katapodi, M (2022) Life Course Perspective on the decision-making process to undergo genetic testing in hereditary cancer at risk families. In: 19th Biennal European Society for Health and Medical Sociology Conference, 25-27.8.2022, Bologna.

Full text not available from this repository.

Abstract

Facilitated access to genetic information makes it possible to determine whether an individual is a carrier of a disease-causing variant and to provide clinical management options to reduce disease risk. For pathogenic variants predisposing to early cancer onset, such as BRCA1 or BRCA2 genes, research indicates that up to 50% of individuals from affected families remain unaware of their predisposition, do not get tested, and do not benefit from risk reduction measures. In this presentation we investigate the timing and social aspects - using the Life Course Perspective (LCP) – of decision-making processes leading to undergoing, deferring or foregoing Hereditary Breast and Ovarian Cancer (HBOC) genetic testing.

Actions (login required)

View Item View Item